Picture of Aptinyx logo

APTX — Aptinyx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aptinyx Reports Qtrly Net Loss Per Share $0.29

Aug 10 (Reuters) - Aptinyx Inc  APTX.O :
    * SAYS CEO NORBERT RIEDEL WILL TRANSITION TO ROLE OF
EXECUTIVE
CHAIRPERSON EFFECTIVE JAN 1,2022 
    * SAYS ANDY KIDD WILL BE APPOINTED CEO EFFECTIVE JAN 1,2022 
    * ENROLLMENT ON TRACK IN BOTH PHASE 2B CHRONIC PAIN STUDIES
WITH
NYX-2925-DATA READOUTS EXPECTED 1H 2022
    * ENROLLMENT ON TRACK IN PHASE 2 COGNITIVE IMPAIRMENT STUDY
WITH
NYX-458-DATA READOUT EXPECTED 2H 2022
    * CASH AND CASH EQUIVALENTS WERE $129.2 MILLION AT JUNE 30,
2021
    * EXPECTS ITS CURRENT CASH BALANCE TO SUPPORT ANTICIPATED
OPERATIONS INTO 2023.
    * QTRLY NET LOSS PER SHARE - BASIC AND DILUTED $0.29
    * Q2 EARNINGS PER SHARE VIEW $-0.25 -- REFINITIV IBES DATA

Further company coverage:  APTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aptinyx

See all news